Mirabegron versus Placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome: a systematic review

Anirban  Dey; G Georgiadis; J Umezurike; Y. Yuan; F Farag; James N'Dow; Muhammad Imran Omar; Charalampos Mamoulakis

Mirabegron versus Placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome: a systematic review

Anirban Dey^* (Corresponding Author), G Georgiadis , J Umezurike , Y. Yuan, F Farag, James N'Dow, Muhammad Imran Omar, Charalampos Mamoulakis

^*Corresponding author for this work

Research output: Contribution to conference › Abstract › peer-review

Abstract

Abstract session 25 - EAU Guidelines: Artificial intelligence and new clinical insights

Original language	English
Publication status	Published - 7 Apr 2024
Event	39th Annual EAU Congress - Paris, France Duration: 5 Apr 2024 → 8 Apr 2024 https://eaucongress.uroweb.org/the-congress/

Conference

Conference	39th Annual EAU Congress
Abbreviated title	EAU24
Country/Territory	France
City	Paris
Period	5/04/24 → 8/04/24
Internet address	https://eaucongress.uroweb.org/the-congress/

Access to Document

https://urosource.uroweb.org/resource-centres/EAU24/257993/abstractLicence: Unspecified

Cite this

Dey, A., Georgiadis , G., Umezurike , J., Yuan, Y., Farag, F., N'Dow, J., Omar, M. I., & Mamoulakis, C. (2024). Mirabegron versus Placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome: a systematic review. Abstract from 39th Annual EAU Congress, Paris, France. https://urosource.uroweb.org/resource-centres/EAU24/257993/abstract

Dey, A, Georgiadis , G, Umezurike , J, Yuan, Y, Farag, F, N'Dow, J , Omar, MI & Mamoulakis, C 2024, 'Mirabegron versus Placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome: a systematic review', 39th Annual EAU Congress, Paris, France, 5/04/24 - 8/04/24. <https://urosource.uroweb.org/resource-centres/EAU24/257993/abstract>

@conference{643cee4518ab4157abf4b9c5a8e9534e,

title = "Mirabegron versus Placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome: a systematic review",

abstract = "Abstract session 25 - EAU Guidelines: Artificial intelligence and new clinical insights",

author = "Anirban Dey and G Georgiadis and J Umezurike and Y. Yuan and F Farag and James N'Dow and Omar, {Muhammad Imran} and Charalampos Mamoulakis",

year = "2024",

month = apr,

day = "7",

language = "English",

note = "39th Annual EAU Congress, EAU24 ; Conference date: 05-04-2024 Through 08-04-2024",

url = " https://eaucongress.uroweb.org/the-congress/",

}

TY - CONF

T1 - Mirabegron versus Placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome

T2 - 39th Annual EAU Congress

AU - Dey, Anirban

AU - Georgiadis , G

AU - Umezurike , J

AU - Yuan, Y.

AU - Farag, F

AU - N'Dow, James

AU - Omar, Muhammad Imran

AU - Mamoulakis, Charalampos

PY - 2024/4/7

Y1 - 2024/4/7

N2 - Abstract session 25 - EAU Guidelines: Artificial intelligence and new clinical insights

AB - Abstract session 25 - EAU Guidelines: Artificial intelligence and new clinical insights

M3 - Abstract

Y2 - 5 April 2024 through 8 April 2024

ER -

Mirabegron versus Placebo and other therapeutic modalities in the treatment of patients with Overactive Bladder Syndrome: a systematic review

Abstract

Conference

Access to Document

Fingerprint

Cite this